HighTide Therapeutics, Inc. (HKG:2511)
3.140
+0.190 (6.44%)
May 20, 2025, 11:35 AM HKT
HighTide Therapeutics Market Cap
HighTide Therapeutics has a market cap or net worth of 1.52 billion as of May 19, 2025. Its market cap has decreased by -39.43% in one year.
Market Cap
1.52B
Enterprise Value
1.08B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
3.14
Market Cap Chart
Since December 22, 2023, HighTide Therapeutics's market cap has decreased from 6.37B to 1.52B, a decrease of -76.17%. That is a compound annual growth rate of -63.89%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 19, 2025 | 1.52B | 132.28% |
Dec 31, 2024 | 653.76M | -90.20% |
Dec 29, 2023 | 6.67B | 4.68% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
BeiGene | 193.02B |
Hansoh Pharmaceutical Group Company | 139.43B |
JD Health International | 129.52B |
WuXi Biologics | 95.65B |
Alibaba Health Information Technology | 84.43B |
Innovent Biologics | 84.13B |
Akeso | 74.95B |
Sino Biopharmaceutical | 72.47B |